Racemic crystallography

Last updated January 09, 2024

Racemic crystallography is a technique used in structural biology where crystals of a protein molecule are developed from an equimolar mixture of an L-protein molecule of natural chirality and its D-protein mirror image.^[1]^[2] L-protein molecules consist of 'left-handed' L-amino acids and the achiral amino acid glycine, whereas the mirror image D-protein molecules consist of 'right-handed' D-amino acids and glycine. Typically, both the L-protein and the D-protein are prepared by total chemical synthesis.

Manufacturing

Native chemical ligation of unprotected peptide segments is used to prepare the protein's polypeptide chain, which is then folded to form a protein molecule.^[1] In native chemical ligation, a peptide C-terminal thioester reacts with a second peptide that has a cysteine residue at its N-terminus, to give a product with a peptide bond at the ligation site.^[3] Multiple unprotected peptide segments can be linked in this way to give the full length polypeptide chain, which is folded to give the target protein molecule. Once the chemical synthesis of an L-protein is achieved, the D-protein enantiomer can be manufactured using synthetic peptide building blocks made from D-amino acids and Gly.^[1] Convergent synthesis is most effective in preparing long polypeptide chains, by using peptide-hydrazides, where the hydrazide can be converted to a thioester for use in native chemical ligation. The hydrazide is stable to native chemical ligation reaction conditions, and can be converted in situ to a reactive peptide-thioester for the next native chemical ligation condensation reaction.^[4]

Theory

There are just 230 different ways of arranging objects in regular three-dimensional arrays. In molecular crystallography, these arrangements are called 'space groups'. However, only 65 of these arrangements are accessible to chiral objects or chiral molecules. The remaining 165 space groups contain either a center of symmetry or a mirror plane and are thus not accessible to natural globular proteins, which are chiral molecules. Wukowitz and Yeates developed a mathematical theory to explain the preference of globular proteins to crystallize in certain space groups. They suggested the preferred space group was determined by the number of degrees of freedom (D) or dimensionality as a measure of the ease with which a given symmetry can be formed. They analyzed the number of degrees of freedom for both chiral and achiral space groups where it was found that the space group P1(bar) with D=8 is theoretically the most dominant space group. Since the achiral space group had a higher degree of freedom compared to the chiral space groups, they predicted that racemic mixtures of protein enantiomers would crystallize more readily compared to the natural L-proteins alone by forming achiral {L-protein plus D-protein} pairs. While space group P1(bar) is most preferred, P21/c and C2/c are also highly preferred, whereas the other achiral space groups are expected to appear less frequently. Hence, P1(bar), P21/c, and C2/c are considered common centrosymmetric space groups in racemic mixtures.^[1]

Developments and applications

History

In 1989, Alan Mackay suggested that if chemical synthesis could be used to make L-protein and D-protein enantiomers, it would enable the use of racemic mixtures to crystallize proteins in centrosymmetric space groups. He stated that, because in the X-ray diffraction data obtained from a centrosymmetric crystal the off-diagonal phases would cancel giving phases that differ by 180 degrees, this would facilitate solving the phase problem in protein structure determination through X-ray crystallography.^[4]

In 1993, Laura Zawadzke and Jeremy Berg first used the small (45 amino acids) protein rubredoxin to synthesize it in racemic form. This was done since the structural determination would potentially be easier and more robust by using diffraction data from a centrosymmetric crystal, which requires growth from a racemic mixture. By having a centre of symmetry formed by the racemic protein pairs, the steps of phasing diffraction in data analysis would be further simplified.^[5] As mentioned above, in 1995 Stephanie Wukovitz and Todd Yeates had developed a mathematical theory to explain why protein molecules tend to crystallize more frequently in certain space groups than in others; they predicted that the most favored protein space group would be P1<bar>, and predicted that globular proteins would crystallize more easily as racemates, from a racemic protein mixture.^[6]

Notable applications

With the development of native chemical ligation in 1994, total chemical synthesis of pairs of D-protein and L-protein enantiomers became feasible. In the first practical application to solving an unknown structure, racemic and quasi-racemic X-ray crystallography were used to determine the structure of snow flea anti-freeze protein. In the course of that work it was observed that racemic and even quasi-racemic protein mixtures dramatically facilitated the formation of diffraction quality, centrosymmetric crystals. Quasi-racemates are formed by mirror image protein molecules that are not true enantiomers but which are sufficiently similar mirror image objects to form ordered pseudo-centrosymmetric arrays.^[4]

Subsequently, pairs of racemic and quasi-racemic protein molecules prepared by total chemical synthesis have been shown to dramatically increase the rate of success in forming diffraction-quality crystals from a wide range of globular protein molecules.^[7]

Rv1738, a protein of Mycobacterium tuberculosis is the most up-regulated gene product when M. tb enters persistent dormancy. Preparations of recombinantly expressed Rv1738 L-protein resisted extensive attempts to form crystals. A racemic mixture of the chemically synthesized D-protein and L-protein forms of Rv1738 gave crystals in the centrosymmetric space group C2/c. The structure, containing L-protein and D-protein dimers in a centrosymmetric space group, revealed structural similarity to 'hibernation-promoting factors' that can bind to ribosomes and suppress translation.^[8]

Crystallization of ubiquitin protein was successfully done using racemic crystallography. Crystallization of either D-ubiquitin or L-ubiquitin alone is difficult, whereas a racemic mixture of D-ubiquitin and L-ubiquitin was readily crystallized and diffraction quality crystals were obtained overnight in almost half the conditions tested in a standard commercial crystallization screen.^[4]

Crystallization of racemates of disulfide-containing microprotein molecules was used to determine the structure of trypsin inhibitor SFTI-1 (14 amino acids,1 disulfide), conotoxin cVc1.1 (22 amino acids, 2 disul-fides) and cyclotide kB1 (29 amino acids, 3 disulfides). Using X-ray diffraction, it was found that the racemates crystallized in the centrosymmetric spacegroups P3(bar), Pbca and P1(bar).^[4]

Interestingly, achiral "'peptoid'" chains were found to fold as racemic pairs and crystallize in highly preferred centrosymmetric space groups.

A high-resolution crystal structure of the racemate of a heterochiral D-protein complex with vascular endothelial growth factor A (VEGF-A). The mirror image D-protein form of VEGF-A was used in phage display to identify a 56 residue L-protein binder with nanomolar affinity; the chemically synthesized D-protein binder had the same affinity for the L-protein form of VEGF-A. A mixture of chemically synthesized proteins consisting of D-VEGF-A, L-VEGF-A, and two equivalents each of the D-protein binder and L-protein binder, gave racemic crystals in the centrosymmetric space group P21/n. The structure of this 71kDa heterochiral protein complex was solved at a resolution of 1.6 Å ^[4]

Related Research Articles

In chemistry, a racemic mixture or racemate, is one that has equal amounts of left- and right-handed enantiomers of a chiral molecule or salt. Racemic mixtures are rare in nature, but many compounds are produced industrially as racemates.

In chemistry, an enantiomer – also called optical isomer, antipode, or optical antipode – is one of two stereoisomers that are non-superposable onto their own mirror image. Enantiomers are much like one's right and left hands; without mirroring one of them, hands cannot be superposed onto each other. No amount of reorientation in three spatial dimensions will allow the four unique groups on the chiral carbon to line up exactly. The number of stereoisomers a molecule has can be determined by the number of chiral carbons it has. Stereoisomers include both enantiomers and diastereomers.

In chemistry, racemization is a conversion, by heat or by chemical reaction, of an optically active compound into a racemic form. This creates a 1:1 molar ratio of enantiomers and is referred to as a racemic mixture. Plus and minus forms are called Dextrorotation and levorotation. The D and L enantiomers are present in equal quantities, the resulting sample is described as a racemic mixture or a racemate. Racemization can proceed through a number of different mechanisms, and it has particular significance in pharmacology as different enantiomers may have different pharmaceutical effects.

In chemistry, a molecule or ion is called chiral if it cannot be superposed on its mirror image by any combination of rotations, translations, and some conformational changes. This geometric property is called chirality. The terms are derived from Ancient Greek χείρ (cheir) 'hand'; which is the canonical example of an object with this property.

Enantioselective synthesis, also called asymmetric synthesis, is a form of chemical synthesis. It is defined by IUPAC as "a chemical reaction in which one or more new elements of chirality are formed in a substrate molecule and which produces the stereoisomeric products in unequal amounts."

Homochirality is a uniformity of chirality, or handedness. Objects are chiral when they cannot be superposed on their mirror images. For example, the left and right hands of a human are approximately mirror images of each other but are not their own mirror images, so they are chiral. In biology, 19 of the 20 natural amino acids are homochiral, being L-chiral (left-handed), while sugars are D-chiral (right-handed). Homochirality can also refer to enantiopure substances in which all the constituents are the same enantiomer, but some sources discourage this use of the term.

Biocatalysis refers to the use of living (biological) systems or their parts to speed up (catalyze) chemical reactions. In biocatalytic processes, natural catalysts, such as enzymes, perform chemical transformations on organic compounds. Both enzymes that have been more or less isolated and enzymes still residing inside living cells are employed for this task. Modern biotechnology, specifically directed evolution, has made the production of modified or non-natural enzymes possible. This has enabled the development of enzymes that can catalyze novel small molecule transformations that may be difficult or impossible using classical synthetic organic chemistry. Utilizing natural or modified enzymes to perform organic synthesis is termed chemoenzymatic synthesis; the reactions performed by the enzyme are classified as chemoenzymatic reactions.

Stephen B. H. Kent is a professor at the University of Chicago. While professor at the Scripps Research Institute in the early 1990s he pioneered modern ligation methods for the total chemical synthesis of proteins. He was the inventor of native chemical ligation together with his student Philip Dawson. His laboratory experimentally demonstrated the principle that chemical synthesis of a protein's polypeptide chain using mirror-image amino acids after folding results in a mirror-image protein molecule which, if an enzyme, will catalyze a chemical reaction with mirror-image stereospecificity. At the University of Chicago Kent and his junior colleagues pioneered the elucidation of protein structures by quasi-racemic & racemic crystallography.

The molecular configuration of a molecule is the permanent geometry that results from the spatial arrangement of its bonds. The ability of the same set of atoms to form two or more molecules with different configurations is stereoisomerism. This is distinct from constitutional isomerism which arises from atoms being connected in a different order. Conformers which arise from single bond rotations, if not isolatable as atropisomers, do not count as distinct molecular configurations as the spatial connectivity of bonds is identical.

Ronald Charles David Breslow was an American chemist from Rahway, New Jersey. He was University Professor at Columbia University, where he was based in the Department of Chemistry and affiliated with the Departments of Biological Sciences and Pharmacology; he had also been on the faculty of its Department of Chemical Engineering. He had taught at Columbia since 1956 and was a former chair of the university's chemistry department.

Chiral resolution, or enantiomeric resolution, is a process in stereochemistry for the separation of racemic mixture into their enantiomers. It is an important tool in the production of optically active compounds, including drugs. Another term with the same meaning is optical resolution.

Absolute configuration refers to the spatial arrangement of atoms within a chiral molecular entity and its resultant stereochemical description. Absolute configuration is typically relevant in organic molecules where carbon is bonded to four different substituents. This type of construction creates two possible enantiomers. Absolute configuration uses a set of rules to describe the relative positions of each bond around the chiral center atom. The most common labeling method uses the descriptors R or S and is based on the Cahn–Ingold–Prelog priority rules. R and S refer to rectus and sinister, Latin for right and left, respectively.

Diastereomeric recrystallisation is a method of chiral resolution of enantiomers from a racemic mixture. It differs from asymmetric synthesis, which aims to produce a single enantiomer from the beginning, in that diastereomeric recrystallisation separates two enantiomers that have already mixed into a single solution. The strategy of diastereomeric recrystallisation involves two steps. The first step is to convert the enantiomers into diastereomers by way of a chemical reaction. A mixture of enantiomers may contain two isomers of a molecule with one chiral center. After adding a second chiral center in a determined location, the two isomers are still different, but they are no longer mirror images of each other; rather, they become diastereomers.

An enantiopure drug is a pharmaceutical that is available in one specific enantiomeric form. Most biological molecules are present in only one of many chiral forms, so different enantiomers of a chiral drug molecule bind differently to target receptors. Chirality can be observed when the geometric properties of an object is not superimposable with its mirror image. Two forms of a molecule are formed from a chiral carbon, these two forms are called enantiomers. One enantiomer of a drug may have a desired beneficial effect while the other may cause serious and undesired side effects, or sometimes even beneficial but entirely different effects. The desired enantiomer is known as an eutomer while the undesired enantiomer is known as the distomer. When equal amounts of both enantiomers are found in a mixture, the mixture is known as a racemic mixture. If a mixture for a drug does not have a 1:1 ratio of its enantiomers it is a candidate for an enantiopure drug. Advances in industrial chemical processes have made it economical for pharmaceutical manufacturers to take drugs that were originally marketed as a racemic mixture and market the individual enantiomers, either by specifically manufacturing the desired enantiomer or by resolving a racemic mixture. On a case-by-case basis, the U.S. Food and Drug Administration (FDA) has allowed single enantiomers of certain drugs to be marketed under a different name than the racemic mixture. Also case-by-case, the United States Patent Office has granted patents for single enantiomers of certain drugs. The regulatory review for marketing approval and for patenting is independent, and differs country by country.

The eudysmic ratio represents the difference in pharmacologic activity between the two enantiomers of a drug. In most cases where a chiral compound is biologically active, one enantiomer is more active than the other. The eudysmic ratio is the ratio of activity between the two. A eudysmic ratio significantly differing from 1 means that they are statistically different in activity. Eudisimic ratio (ER) reflects the degree of enantioselectivity of the biological systems. For example, (S)-propranolol meaning that (S)-propranolol is 130 times more active as its (R)-enantiomer.

Asymmetric ester hydrolysis with pig liver esterase is the enantioselective conversion of an ester to a carboxylic acid through the action of the enzyme pig liver esterase. Asymmetric ester hydrolysis involves the selective reaction of one of a pair of either enantiotopic or enantiomorphic ester groups.

Chirality is a property of asymmetry important in several branches of science. The word chirality is derived from the Greek χειρ (kheir), "hand", a familiar chiral object.

ᴅ-Amino acids are amino acids where the stereogenic carbon alpha to the amino group has the ᴅ-configuration. For most naturally-occurring amino acids, this carbon has the ʟ-configuration. ᴅ-Amino acids are occasionally found in nature as residues in proteins. They are formed from ribosomally-derived ᴅ-amino acid residues.

Viedma ripening or attrition-enhanced deracemization is a chiral symmetry breaking phenomenon observed in solid/liquid mixtures of enantiomorphous crystals that are subjected to comminution. It can be classified in the wider area of spontaneous symmetry breaking phenomena observed in chemistry and physics.

Chemical compounds that come as mirror-image pairs are referred to by chemists as chiral or handed molecules. Each twin is called an enantiomer. Drugs that exhibit handedness are referred to as chiral drugs. Chiral drugs that are equimolar (1:1) mixture of enantiomers are called racemic drugs and these are obviously devoid of optical rotation. The most commonly encountered stereogenic unit, that confers chirality to drug molecules are stereogenic center. Stereogenic center can be due to the presence of tetrahedral tetra coordinate atoms (C,N,P) and pyramidal tricoordinate atoms (N,S). The word chiral describes the three-dimensional architecture of the molecule and does not reveal the stereochemical composition. Hence "chiral drug" does not say whether the drug is racemic, single enantiomer or some other combination of stereoisomers. To resolve this issue Joseph Gal introduced a new term called unichiral. Unichiral indicates that the stereochemical composition of a chiral drug is homogenous consisting of a single enantiomer.

References

1 2 3 4 Yeates TO, Kent SB (2012-06-09). "Racemic protein crystallography". Annual Review of Biophysics. 41 (1): 41–61. doi:10.1146/annurev-biophys-050511-102333. PMID 22443988.
↑ Matthews BW (June 2009). "Racemic crystallography--easy crystals and easy structures: what's not to like?". Protein Science. 18 (6): 1135–1138. doi:10.1002/pro.125. PMC 2774423 . PMID 19472321.
↑ Agouridas V, El Mahdi O, Diemer V, Cargoët M, Monbaliu JM, Melnyk O (June 2019). "Native Chemical Ligation and Extended Methods: Mechanisms, Catalysis, Scope, and Limitations". Chemical Reviews. 119 (12): 7328–7443. doi:10.1021/acs.chemrev.8b00712. PMID 31050890. S2CID 145023266.
1 2 3 4 5 6 Kent SB (October 2018). "Racemic & quasi-racemic protein crystallography enabled by chemical protein synthesis". Current Opinion in Chemical Biology. Synthetic Biology / Synthetic Biomolecules. 46: 1–9. doi:10.1016/j.cbpa.2018.03.012. PMID 29626784. S2CID 4680759.
↑ Zawadzke LE, Berg JM (July 1993). "The structure of a centrosymmetric protein crystal". Proteins. 16 (3): 301–305. doi:10.1002/prot.340160308. PMID 8346193. S2CID 34216468.
↑ Wukovitz SW, Yeates TO (December 1995). "Why protein crystals favour some space-groups over others". Nature Structural Biology. 2 (12): 1062–1067. doi:10.1038/nsb1295-1062. PMID 8846217. S2CID 22994029.
↑ Yan B, Ye L, Xu W, Liu L (September 2017). "Recent advances in racemic protein crystallography". Bioorganic & Medicinal Chemistry. Peptide and protein ligation. 25 (18): 4953–4965. doi:10.1016/j.bmc.2017.05.020. PMID 28705433.
↑ Bunker RD, Mandal K, Bashiri G, Chaston JJ, Pentelute BL, Lott JS, et al. (April 2015). "A functional role of Rv1738 in Mycobacterium tuberculosis persistence suggested by racemic protein crystallography". Proceedings of the National Academy of Sciences of the United States of America. 112 (14): 4310–4315. doi: 10.1073/pnas.1422387112 . PMC 4394262 . PMID 25831534.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[:02-1] 1 2 3 4 Yeates TO, Kent SB (2012-06-09). "Racemic protein crystallography". Annual Review of Biophysics. 41 (1): 41–61. doi:10.1146/annurev-biophys-050511-102333. PMID 22443988.

[2] Matthews BW (June 2009). "Racemic crystallography--easy crystals and easy structures: what's not to like?". Protein Science. 18 (6): 1135–1138. doi:10.1002/pro.125. PMC 2774423 . PMID 19472321.

[3] Agouridas V, El Mahdi O, Diemer V, Cargoët M, Monbaliu JM, Melnyk O (June 2019). "Native Chemical Ligation and Extended Methods: Mechanisms, Catalysis, Scope, and Limitations". Chemical Reviews. 119 (12): 7328–7443. doi:10.1021/acs.chemrev.8b00712. PMID 31050890. S2CID 145023266.

[:1-4] 1 2 3 4 5 6 Kent SB (October 2018). "Racemic & quasi-racemic protein crystallography enabled by chemical protein synthesis". Current Opinion in Chemical Biology. Synthetic Biology / Synthetic Biomolecules. 46: 1–9. doi:10.1016/j.cbpa.2018.03.012. PMID 29626784. S2CID 4680759.

[5] Zawadzke LE, Berg JM (July 1993). "The structure of a centrosymmetric protein crystal". Proteins. 16 (3): 301–305. doi:10.1002/prot.340160308. PMID 8346193. S2CID 34216468.

[6] Wukovitz SW, Yeates TO (December 1995). "Why protein crystals favour some space-groups over others". Nature Structural Biology. 2 (12): 1062–1067. doi:10.1038/nsb1295-1062. PMID 8846217. S2CID 22994029.

[7] Yan B, Ye L, Xu W, Liu L (September 2017). "Recent advances in racemic protein crystallography". Bioorganic & Medicinal Chemistry. Peptide and protein ligation. 25 (18): 4953–4965. doi:10.1016/j.bmc.2017.05.020. PMID 28705433.

[8] Bunker RD, Mandal K, Bashiri G, Chaston JJ, Pentelute BL, Lott JS, et al. (April 2015). "A functional role of Rv1738 in Mycobacterium tuberculosis persistence suggested by racemic protein crystallography". Proceedings of the National Academy of Sciences of the United States of America. 112 (14): 4310–4315. doi: 10.1073/pnas.1422387112 . PMC 4394262 . PMID 25831534.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]